Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Reducing the Burden of Chemoradiotherapy with the Combination of Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

Jessica C. Hochberg, MD, Jaclyn Basso, RN, MSN, PNP, Liana Klejmont, Pharm D, Lauren Harrison, RN, MSN, Allyson M. Flower, MD, Aliza Gardenswartz, MD, Qiuhu Shi, PhD, Perry Gerard, MD MBA, FACR, Humayan Islam, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 127.

https://doi.org/10.1182/blood-2019-128684

Published: 2019

Journal Articles

Pre-BCR Surrogate Light Chain Components VPREB1 and IGLL1 Function As Pre-BCR-Independent Tumor Suppressors in Acute Lymphoblastic Leukemia

Kadriye Nehir Cosgun, PhD, Rudi W Hendriks, PhD, Ross A Dickins, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD

Blood (2018) 132 (Supplement 1): 570.

https://doi.org/10.1182/blood-2018-99-115522

Published: 2018

Journal Articles

Chimeric Antigen Receptor T Cells Redirected Towards Clonally Restricted Surface Immunoglobulin Efficiently Eradicate Mature B Lymphocyte-Derived Malignancies

Raghuveer Ranganathan, MD

Blood (2018) 132 (Supplement 1): 337.

https://doi.org/10.1182/blood-2018-99-110835

Published: 2018

Journal Articles

Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100

Cindy Eunhee Lee, David A. Fulcher, Belinda Whittle, Rochna Chand, Nicole Fewings, Matthew Field, Daniel Andrews, Christopher C. Goodnow, Matthew C. Cook

Blood (2014) 124 (19): 2964–2972.

https://doi.org/10.1182/blood-2014-06-578542

Published: 2014

Includes: Supplemental data

Journal Articles

Occurence of Malignancies in Patients with Primary Immunodeficiencies: An Analysis of the French Primary Immunodeficency Registry

Felipe Suarez, MD, PhD, Hugo Chapdelaine, M.D., Laetitia Compain, Nizar Mahlaoui, MD, Chantal Andriamanga, M.D, Alain Fischer, Olivier Hermine, MD, PhD

Blood (2012) 120 (21): 1057.

https://doi.org/10.1182/blood.V120.21.1057.1057

Published: 2012

Journal Articles

Whole-Exome Sequencing Links CARD11 Inactivation with SCID

Johann Greil, MD, Tobias Rausch, PhD, Thomas Giese, MD, Obul Reddy Bandapalli, PhD, Volker Daniel, MD, PhD, Isabelle Bekeredjian-Ding, PhD, Adrian M Stuetz, PhD, Christoph Drees, PhD, Susanne Roth, MD, Jürgen Ruland, MD, Jan Korbel, PhD, Andreas E Kulozik, MD, PhD

Blood (2012) 120 (21): 258.

https://doi.org/10.1182/blood.V120.21.258.258

Published: 2012

Journal Articles

Agammaglobulinemia associated with BCR − B cells and enhanced expression of CD19

A. Kerry Dobbs, Amma Bosompem, Elaine Coustan-Smith, Gayle Tyerman, Frank T. Saulsbury, Mary Ellen Conley

Blood (2011) 118 (7): 1828–1837.

https://doi.org/10.1182/blood-2011-01-330472

Published: 2011

Includes: Supplemental data

Journal Articles

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Christoph Königs, Dominik Dunsch, Richard Linde, Thomas Klingebiel, Prof, Dr, Wolfhart Kreuz, PD

Blood (2004) 104 (11): 3832.

https://doi.org/10.1182/blood.V104.11.3832.3832

Published: 2004

Journal Articles

Defective B-cell-negative selection and terminal differentiation in the ICF syndrome

Carla E. Blanco-Betancourt, Anne Moncla, Michèle Milili, Yun Liang Jiang, Evani M. Viegas-Péquignot, Bertrand Roquelaure, Isabelle Thuret, Claudine Schiff

Blood (2004) 103 (7): 2683–2690.

https://doi.org/10.1182/blood-2003-08-2632

Published: 2004

Journal Articles

Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation

Hidetoshi Takada, Hirokazu Kanegane, Akihiko Nomura, Ken Yamamoto, Kenji Ihara, Yasuhiko Takahashi, Satoshi Tsukada, Toshio Miyawaki, Toshiro Hara

Blood (2004) 103 (1): 185–187.

https://doi.org/10.1182/blood-2003-06-1964

Published: 2004

Journal Articles

Fates of human B-cell precursors

Tucker W. LeBien

Blood (2000) 96 (1): 9–23.

https://doi.org/10.1182/blood.V96.1.9

Published: 2000

NARROW

Reducing the Burden of Chemoradiotherapy with the Combination of Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

Pre-BCR Surrogate Light Chain Components VPREB1 and IGLL1 Function As Pre-BCR-Independent Tumor Suppressors in Acute Lymphoblastic Leukemia

Chimeric Antigen Receptor T Cells Redirected Towards Clonally Restricted Surface Immunoglobulin Efficiently Eradicate Mature B Lymphocyte-Derived Malignancies

Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100

Occurence of Malignancies in Patients with Primary Immunodeficiencies: An Analysis of the French Primary Immunodeficency Registry

Whole-Exome Sequencing Links CARD11 Inactivation with SCID

Agammaglobulinemia associated with BCR − B cells and enhanced expression of CD19

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Defective B-cell-negative selection and terminal differentiation in the ICF syndrome

Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation

Fates of human B-cell precursors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only